Effect of hypertonic saline and macrophage migration inhibitory factor in restoration of T cell dysfunction

Journal of the Korean Surgical Society

Volumn 81, Issue 4, 2011, Pages 229-234

  Yoon, Young Hoon ^a   Choi, Sung Hyuk ^a   Hong, Yun Sik ^a   Lee, Sung Woo ^a   Moon, Sung Woo ^a   Cho, Han Jin ^a   Han, Cheul ^b   Cheon, Young Jin ^b   Bansal, Vishal ^c  

^a Korea University College of Medicine   (South Korea)

^b Ewha Womans University School of Medicine   (South Korea)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Hypertonic solutions; Injuries; Macrophage Migration Inhibitory factors; Prostaglandins E; T lymphocytes

Indexed keywords

EID: 81055137614     PISSN: 12260053     EISSN: 20930488     Source Type: Journal    
DOI: 10.4174/jkss.2011.81.4.229     Document Type: Article

References (25)

1. Napolitano LM, Faist E, Wichmann MW, Coimbra R. Immune dysfunction in trauma. Surg Clin North Am 1999; 79: 1385-416.
2. Coimbra R, Junger WG, Liu FC, Loomis WH, Hoyt DB. Hypertonic/hyperoncotic fluids reverse prostaglandin E2 (PGE2)-induced T-cell suppression. Shock 1995; 4: 45-9.
3. Bacher M, Metz CN, Calandra T, Mayer K, Chesney J, Lohoff M, et al. An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc Natl Acad Sci U S A 1996; 93: 7849-54. (Pubitemid 26277127)
4. Bernhagen J, Calandra T, Bucala R. Regulation of the immune response by macrophage migration inhibitory factor: biological and structural features. J Mol Med (Berl) 1998; 76: 151-61. (Pubitemid 28098701)
5. Lee JY, Song SU, Shin SH. Normal serum macrophage migration inhibitory factor concentrations of Korean people according to age. J Korean Geriatr Soc 2004; 8: 165-9.
6. Lehmann LE, Novender U, Schroeder S, Pietsch T, von Spiegel T, Putensen C, et al. Plasma levels of macrophage migration inhibitory factor are elevated in patients with severe sepsis. Intensive Care Med 2001; 27: 1412-5. (Pubitemid 32758941)
7. Lehmann LE, Weber SU, Fuchs D, Klaschik S, Schewe JC, Book M, et al. Intracellular detection of macrophage migration inhibitory factor in peripheral blood leukocytes. Free Radic Biol Med 2005; 38: 1170-9. (Pubitemid 40445533)
8. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-54.
9. Smith JW, Gamelli RL, Jones SB, Shankar R. Immunologic responses to critical injury and sepsis. J Intensive Care Med 2006; 21: 160-72.
10. Lee JS, Han C, Cho SN, Chung SY. Effect of rapamycin on the cell cycle arrest of T lymphocytes. J Korean Surg Soc 2007; 73: 13-20.
11. Park MH, Lee CS, Cho MH, Han C, Koh YS, Kim JC, et al. In vitro induction of carcinoembryonic antigen (CEA) specific cytotoxic T lymphocytes using dendritic cells pulsed with CEA peptide. J Korean Surg Soc 2005; 69: 359-66.
12. Santoli D, Phillips PD, Colt TL, Zurier RB. Suppression of interleukin 2-dependent human T cell growth in vitro by prostaglandin E (PGE) and their precursor fatty acids. Evidence for a PGE-independent mechanism of inhibition by the fatty acids. J Clin Invest 1990; 85: 424-32. (Pubitemid 20070048)
13. Roper RL, Phipps RP. Prostaglandin E2 regulation of the immune response. Adv Prostaglandin Thromboxane Leukot Res 1994; 22: 101-11.
14. Anastassiou ED, Paliogianni F, Balow JP, Yamada H, Boumpas DT. Prostaglandin E2 and other cyclic AMP-elevating agents modulate IL-2 and IL-2R alpha gene expression at multiple levels. J Immunol 1992; 148: 2845-52.
15. van Oirschot BA, Stahl M, Lens SM, Medema RH. Protein kinase A regulates expression of p27(kip1) and cyclin D3 to suppress proliferation of leukemic T cell lines. J Biol Chem 2001; 276: 33854-60.
16. Hoyt DB, Junger WG, Loomis WH, Liu FC. Effects of trauma on immune cell function: impairment of intracellular calcium signaling. Shock 1994; 2: 23-8.
17. Junger WG, Liu FC, Loomis WH, Hoyt DB. Hypertonic saline enhances cellular immune function. Circ Shock 1994; 42: 190-6. (Pubitemid 24155551)
18. Choi SH, Bansal V, Costantini T, Putnam J, Loomis W, Coimbra R. Arginine is essential in reversing prostaglandin E(2) T-cell suppression by hypertonic saline. J Surg Res 2009; 156: 83-9.
19. Larson DF, Horak K. Macrophage migration inhibitory factor: controller of systemic inflammation. Crit Care 2006; 10: 138.
20. Lue H, Kleemann R, Calandra T, Roger T, Bernhagen J. Macrophage migration inhibitory factor (MIF): mechanisms of action and role in disease. Microbes Infect 2002; 4: 449-60. (Pubitemid 34270682)
21. Mitchell RA, Liao H, Chesney J, Fingerle-Rowson G, Baugh J, David J, et al. Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response. Proc Natl Acad Sci U S A 2002; 99: 345-50. (Pubitemid 34060365)
22. Nguyen MT, Lue H, Kleemann R, Thiele M, Tolle G, Finkelmeier D, et al. The cytokine macrophage migration inhibitory factor reduces pro-oxidative stress-induced apoptosis. J Immunol 2003; 170: 3337-47. (Pubitemid 36302213)
23. Kleemann R, Hausser A, Geiger G, Mischke R, Burger-Kentischer A, Flieger O, et al. Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1. Nature 2000; 408: 211-6.
24. Mitchell RA, Bucala R. Tumor growth-promoting properties of macrophage migration inhibitory factor (MIF). Semin Cancer Biol 2000; 10: 359-66.
25. Cho ML, Moon YM, Heo YJ, Woo YJ, Ju JH, Park KS, et al. NF-kappaB inhibition leads to increased synthesis and secretion of MIF in human CD4+ T cells. Immunol Lett 2009; 123: 21-30.